论文部分内容阅读
目的:对体外反搏及中医药治疗冠心病不稳定型心绞痛进行系统临床疗效观察比较。方法:将160例随机分成4组,分别为对照组38例、中药治疗组43例、体外反搏治疗组40例、中药联合体外反搏治疗组39例,观察4组患者的临床疗效情况。结果:对照组、中药治疗组、体外反搏治疗组、中药联合体外反搏治疗组症状改善总有效率分别为68.4%,76.8%,75.0%,82.9%,心电图改善总有效率分别为68.4%,74.4%,72.5%,82.9%,对照组与中药治疗组比较差异有统计学意义(P<0.05),对照组与体外反搏治疗组比较差异有统计学意义(P<0.05),对照组与中药联合体外反搏治疗组比较差异有明显统计学意义(P<0.01)。结论:中药及体外反搏的应用为临床治疗冠心病不稳定型心绞痛增加了新的更为有效的治疗方案。
Objective: To compare the clinical efficacy of EECP and Chinese medicine in treating unstable angina pectoris of coronary heart disease. Methods: 160 cases were randomly divided into 4 groups, including 38 cases in the control group, 43 cases in the traditional Chinese medicine treatment group, 40 cases in the EECP treatment group and 39 cases in the ECHP group. The clinical curative effect was observed in 4 groups. Results: The total effective rates of the control group, the traditional Chinese medicine treatment group, the EECP treatment group and the traditional Chinese medicine combined with EECP group were 68.4%, 76.8%, 75.0% and 82.9% respectively. The total effective rates of ECG improvement were 68.4%, 68.8% , 74.4%, 72.5% and 82.9% respectively. The difference between the control group and the traditional Chinese medicine treatment group was statistically significant (P <0.05), and the difference between the control group and the EECP treatment group was statistically significant (P <0.05) Compared with traditional Chinese medicine combined with EECP, the difference was statistically significant (P <0.01). Conclusion: The application of traditional Chinese medicine and external counterpulsation adds new and more effective treatment for the clinical treatment of unstable angina pectoris.